Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Understanding the potential role of statins in pneumonia and sepsis.

Yende S, Milbrandt EB, Kellum JA, Kong L, Delude RL, Weissfeld LA, Angus DC.

Crit Care Med. 2011 Aug;39(8):1871-8. doi: 10.1097/CCM.0b013e31821b8290.

2.

What is the real role of statins in community-acquired pneumonia and sepsis?

Valente Barbas CS, Barbosa Kawano-Dourado L.

Crit Care Med. 2011 Aug;39(8):1998-2000. doi: 10.1097/CCM.0b013e31821f02a8. No abstract available.

PMID:
21768804
3.

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study.

Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ.

BMJ. 2006 Nov 11;333(7576):999. Epub 2006 Oct 23.

4.

Association of statin use with risk and outcome of acute kidney injury in community-acquired pneumonia.

Murugan R, Weissfeld L, Yende S, Singbartl K, Angus DC, Kellum JA; Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators.

Clin J Am Soc Nephrol. 2012 Jun;7(6):895-905. doi: 10.2215/CJN.07100711. Epub 2012 Mar 29.

5.

Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study.

Bruyere R, Vigneron C, Prin S, Pechinot A, Quenot JP, Aho S, Papazian L, Charles PE.

Crit Care. 2014 Apr 28;18(2):R83. doi: 10.1186/cc13845.

6.

Statins and delirium during critical illness: a multicenter, prospective cohort study.

Morandi A, Hughes CG, Thompson JL, Pandharipande PP, Shintani AK, Vasilevskis EE, Han JH, Jackson JC, Laskowitz DT, Bernard GR, Ely EW, Girard TD.

Crit Care Med. 2014 Aug;42(8):1899-909. doi: 10.1097/CCM.0000000000000398.

7.
8.

Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.

Kruger PS, Harward ML, Jones MA, Joyce CJ, Kostner KM, Roberts MS, Venkatesh B.

Am J Respir Crit Care Med. 2011 Mar 15;183(6):774-81. doi: 10.1164/rccm.201006-0955OC. Epub 2010 Oct 19.

PMID:
20959555
9.

Differences in immune response may explain lower survival among older men with pneumonia.

Reade MC, Yende S, D'Angelo G, Kong L, Kellum JA, Barnato AE, Milbrandt EB, Dooley C, Mayr FB, Weissfeld L, Angus DC; Genetic and Inflammatory Markers of Sepsis Investigators.

Crit Care Med. 2009 May;37(5):1655-62. doi: 10.1097/CCM.0b013e31819da853.

10.

The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia.

Kale S, Yende S, Kong L, Perkins A, Kellum JA, Newman AB, Vallejo AN, Angus DC; GenIMS Investigators.

PLoS One. 2010 Nov 4;5(11):e13852. doi: 10.1371/journal.pone.0013852.

11.

Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis.

Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM; Eritoran Sepsis Study Group.

Crit Care Med. 2010 Jan;38(1):72-83. doi: 10.1097/CCM.0b013e3181b07b78. Erratum in: Crit Care Med. 2010 Sep;38(9):1925-6. Multiple investigator names added..

PMID:
19661804
12.

Effect of the use of low and high potency statins and sepsis outcomes.

Ou SY, Chu H, Chao PW, Ou SM, Lee YJ, Kuo SC, Li SY, Shih CJ, Chen YT.

Intensive Care Med. 2014 Oct;40(10):1509-17. doi: 10.1007/s00134-014-3418-1. Epub 2014 Aug 5.

PMID:
25091791
13.

Reduction in mortality associated with statin therapy in patients with severe sepsis.

Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM.

Pharmacotherapy. 2009 Jun;29(6):621-30. doi: 10.1592/phco.29.6.621.

PMID:
19476415
14.

The influence of statin exposure on inflammatory markers in patients with early bacterial infection: pilot prospective cohort study.

Shankar-Hari M, Donnelly A, Pinto R, Salih Z, McKenzie C, Terblanche M, Adhikari NK.

BMC Anesthesiol. 2014 Nov 19;14:106. doi: 10.1186/1471-2253-14-106. eCollection 2014.

15.

Prior statin therapy is associated with a decreased rate of severe sepsis.

Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A.

Circulation. 2004 Aug 17;110(7):880-5. Epub 2004 Aug 2.

16.

Prior statin use is associated with improved outcomes in community-acquired pneumonia.

Chalmers JD, Singanayagam A, Murray MP, Hill AT.

Am J Med. 2008 Nov;121(11):1002-1007.e1. doi: 10.1016/j.amjmed.2008.06.030.

PMID:
18954848
17.

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.

Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, Lafrance JP, Levy A, Garg AX, Ernst P; Canadian Network for Observational Drug Effect Studies.

BMJ. 2013 Mar 18;346:f880. doi: 10.1136/bmj.f880.

18.

A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.

Kruger P, Bailey M, Bellomo R, Cooper DJ, Harward M, Higgins A, Howe B, Jones D, Joyce C, Kostner K, McNeil J, Nichol A, Roberts MS, Syres G, Venkatesh B; ANZ-STATInS Investigators–ANZICS Clinical Trials Group.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):743-50. doi: 10.1164/rccm.201209-1718OC.

PMID:
23348980
19.

Statin use and sepsis events [corrected] in patients with chronic kidney disease.

Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, Levin NW, Powe NR.

JAMA. 2007 Apr 4;297(13):1455-64. Erratum in: JAMA. 2008 Feb 20;299(7):765.

PMID:
17405971
20.

Impact of statins in outcomes of septic patients: a systematic review.

Tralhão AF, Cés de Souza-Dantas V, Salluh JI, Póvoa PM.

Postgrad Med. 2014 Nov;126(7):45-58. doi: 10.3810/pgm.2014.11.2832. Review.

PMID:
25387213
Items per page

Supplemental Content

Write to the Help Desk